Dr. Yogesh S. Jethava, MD

Dr. Jethava practices at Advocate Lutheran General Hospital in Park Ridge, Illinois, part of Advocate Health.

Dr. Jethava's NPI, 1841622701, was assigned on August 2, 2013. Dr. Jethava holds Iowa license MD-46051.

Dr. Jethava's primary practice is Advocate Lutheran General Hospital, at 1775 Dempster St, Park Ridge, IL 60068 in Cook County. The practice phone is (847) 723-2210.

Dr. Jethava's primary practice is Advocate Lutheran General Hospital in Park Ridge, Illinois, part of Advocate Health. Dr. Jethava is also affiliated with University of Iowa Health Care Medical Center. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Jethava to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jethava practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jethava's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Jethava's licenses on file in 3 states: Iowa, Arkansas and Indiana.

CMS data shows 28 Medicare services from Dr. Jethava across 1 procedure code in 2024, for 12 Medicare patients. Medicare paid $1,644 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 12 Medicare patients who saw Dr. Jethava in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jethava's median patient age at 69, with 26% women.

In 2024, Dr. Jethava wrote 17 Medicare Part D claims. 94% of them were for generic drugs. They cover 6 drugs, with $165,801 in total drug cost. In 2022, CMS named 227 claims across 8 drugs.

Dr. Jethava accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Jethava, published from 2018 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Multiple Myeloma, Bortezomib and Drug Resistance, Neoplasm. Dr. Jethava's most frequent co-authors are Michael H. Tomasson, MD, Umar Farooq, MD and Guido Tricot, MD.

CMS Open Payments shows 506 general payments to Dr. Jethava from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Janssen Pharmaceuticals, Inc paid the most, $104,557. It also lists 10 research payments totaling $8,000 from 2020 to 2023.